About Apyx Medical Corporation - Common Stock (APYX)
Apyx Medical Corp is a medical technology company focused on developing innovative solutions for surgical applications. The company specializes in advanced energy-based devices, particularly those that utilize its proprietary Renu™ technology, which enables precise and controlled tissue dissection and coagulation. Apyx Medical's products are designed to enhance surgical outcomes by improving the safety and effectiveness of procedures, while also providing surgeons with state-of-the-art tools that facilitate greater control and efficiency during operations. Through continuous innovation, Apyx aims to meet the evolving needs of healthcare professionals in various surgical specialties. Read More
Apyx Medical (NASDAQ:APYX) reported second-quarter revenue growth of 22% as sales in its surgical aesthetics business increased, led by adoption of its AYON Body Contouring System, international generator sales and domestic demand for single-use handpieces.
Total revenue for the quarter ended June
As the regular session of the US market on Monday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.
As November 20, 2025, unfolds, global financial markets present a landscape of intriguing contrasts, marked by the persistent, transformative power of artificial intelligence and a growing undercurrent of investor caution. While select sectors and geographies celebrate robust growth fueled by technological advancements and strong earnings, broader market sentiment in key
Apyx Medical Q3 2025 earnings beat expectations with a 50% EPS surprise and strong revenue. Stock surges on successful AYON Body Contouring System launch.
APYX Medical Corp reported Q2 2025 results with revenue of $11.37M, missing estimates, but a narrower EPS loss of -$0.09. Stock shows muted reaction amid commercial expansion plans.
